AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Novonesis AS

Director's Dealing Feb 10, 2023

3377_rpt_2023-02-10_1130475a-ccb3-4176-a373-5de620f6f119.pdf

Director's Dealing

Open in Viewer

Opens in native device viewer

Trading by management and close relations of management

In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novozymes reports the following transactions under ISIN DK0060336014, Novozymes B shares under the symbol NZYM B.

February 10, 2023 Company announcement No. 20

Contact information [email protected]

Tobias Cornelius Björklund +45 3077 8682 [email protected]

Ludmila Cebanov +45 3077 0554 [email protected]

Anders Enevoldsen +45 5350 1453 [email protected]

About Novozymes

Novozymes is the world leader in biological solutions. Together with customers, partners and the global community, we improve industrial performance while preserving the planet's resources and helping build better lives. As the world's largest provider of enzyme and microbial technologies, our bioinnovation enables higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel and many other benefits that we rely on today and in the future. We call it Rethink Tomorrow. www.novozymes.com

Novozymes A/S CVR number: 10 00 71 27 LEI: 529900T6WNZXD2R3JW38

Novozymes A/S Krogshoejvej 36 2880 Bagsvaerd Denmark

Phone: +45 4446 0000

1. Details of the person discharging managerial responsibilities/person closely associated
a) Name Amy Byrick
2. Reason for the notification
a) Position/status CEO EVP, Strategy & Business Transformation
b) Initial notification/ Initial notification
Amendment
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auc- tion monitor
a) Name Novozymes A/S
b) LEI 529900T6WNZXD2R3JW38
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii)
each date; and (iv) each place where transactions have been conducted
a) Description of the financial
instrument, type of instrument
Shares
Identification code ISIN DK0060336014
b) Nature of the transaction Purchase of shares
c) Price(s) and volume(s) Price(s) Volume(s)
DKK 346 825 shares
DKK 346
21shares
DKK 346 2,082 shares
DKK 346 413 shares
DKK 346 140 shares
DKK 346 140 shares
DKK 346 165 shares
DKK 345.90 100 shares
DKK 345.90 165 shares
DKK 346 82 shares
DKK 346 5 shares
DKK 346 1 share
DKK 346 72 shares
DKK 346 92 shares
DKK 346 45 shares
d) Aggregated information
-
Aggregated volume
-
Price
Number of shares: 4,348
Average price, DKK: 345.99
Transaction value, DKK: 1,504,364.52

Talk to a Data Expert

Have a question? We'll get back to you promptly.